Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update (Q37054912)

18 August 2017

1 reference

title

Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update (English)

1 reference

18 August 2017

0 references

S H Beachy

1

1 reference

18 August 2017

E A Repasky

series ordinal

2

1 reference

18 August 2017

publication date

10 January 2008

1 reference

Cancer Immunology, Immunotherapy

18 August 2017

published in

1 reference

18 August 2017

volume

57

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

759-775

1 reference

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Pharmacological management of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Global burden of blood-pressure-related disease, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Systolic pressure is all that matters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Blood-pressure screening and supervision in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Estimating the proportion of young adults on antihypertensive treatment that have been correctly diagnosed

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

White-coat hypertension as a cause of cardiovascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

How to measure renal function in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Formula estimation of glomerular filtration rate: have we gone wrong?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

An assessment of the sources of dietary salt in a British population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Atenolol in hypertension: is it a wise choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Major clinical trials of hypertension: what should be done next?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Angioedema due to ACE inhibitors: increased risk in patients of African origin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Calcium antagonist-induced gingival hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Diarrhoea, vomiting and ACE inhibitors:--an important cause of acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Improvement of medication compliance in uncontrolled hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

Commentary: Controversies in NICE guidance on chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.6.759

21 January 2018

Identifiers

DOI

10.2217/14750708.5.6.759

1 reference

18 August 2017

1 reference